EGFR and neoplasm: In conclusion, our study developed a validated non-invasive model (RS-BTIplusVPE) by integrating multi-sequence radiomic model and VPE, which showed improved prediction of EGFR-TKI response in NSCLC patients with brain metastases compared to tumor-focused models.